Van Lanschot Kempen Investment Management N.V. Has $11.72 Million Position in Colgate-Palmolive (NYSE:CL)

Van Lanschot Kempen Investment Management N.V. raised its holdings in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 113.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 128,966 shares of the company's stock after purchasing an additional 68,432 shares during the quarter. Van Lanschot Kempen Investment Management N.V.'s holdings in Colgate-Palmolive were worth $11,724,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of CL. Barclays PLC grew its stake in Colgate-Palmolive by 38.7% in the third quarter. Barclays PLC now owns 7,644,189 shares of the company's stock worth $793,542,000 after purchasing an additional 2,132,747 shares in the last quarter. Te Ahumairangi Investment Management Ltd increased its stake in Colgate-Palmolive by 2.5% during the third quarter. Te Ahumairangi Investment Management Ltd now owns 43,957 shares of the company's stock valued at $4,537,000 after purchasing an additional 1,060 shares during the last quarter. Chelsea Counsel Co. raised its holdings in shares of Colgate-Palmolive by 10.0% during the third quarter. Chelsea Counsel Co. now owns 5,500 shares of the company's stock worth $571,000 after purchasing an additional 500 shares during the period. Fulcrum Equity Management boosted its holdings in shares of Colgate-Palmolive by 3.0% in the 3rd quarter. Fulcrum Equity Management now owns 5,280 shares of the company's stock valued at $548,000 after buying an additional 153 shares during the period. Finally, World Investment Advisors LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $752,000. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on CL. Barclays decreased their target price on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating for the company in a research note on Friday, April 11th. Royal Bank of Canada restated a "sector perform" rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Piper Sandler cut their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research note on Monday, March 31st. Wells Fargo & Company increased their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. Finally, Raymond James reaffirmed an "outperform" rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $102.17.

Colgate-Palmolive Price Performance

Shares of CL traded up $1.20 during mid-day trading on Friday, hitting $93.90. The company's stock had a trading volume of 9,598,477 shares, compared to its average volume of 4,661,866. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The firm has a 50-day moving average price of $92.07 and a 200 day moving average price of $92.23. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock has a market capitalization of $76.16 billion, a price-to-earnings ratio of 26.68, a PEG ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.03. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same quarter in the previous year, the business posted $0.86 earnings per share. On average, research analysts predict that Colgate-Palmolive will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive announced that its board has approved a share repurchase plan on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's management believes its shares are undervalued.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a $0.52 dividend. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.50. The ex-dividend date is Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.22%. Colgate-Palmolive's dividend payout ratio (DPR) is 59.09%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.